Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ramagopal Mudumbi"'
Publikováno v:
Drugs in R&D
The cardiovascular safety profile of dapoxetine, a novel selective serotonin reuptake inhibitor (SSRI) developed as an on-demand oral treatment for premature ejaculation (PE) in men, is evaluated. The cardiovascular assessment of dapoxetine was condu
Autor:
Si Tianmei, Om Sharma, Shean-Sheng Wang, Hsiu-Ling Hsiao, An Vandebosch, An Thyssen, Joseph W. Aquilina, Ramagopal Mudumbi
Publikováno v:
The Journal of Clinical Pharmacology. 50:1450-1460
Dapoxetine is a short-acting selective serotonin reuptake inhibitor developed for the on-demand treatment of premature ejaculation and is approved in some European Union countries, as well as Mexico and Korea, for this indication. The pharmacokinetic
Autor:
David Rivas, Fisseha Tesfaye, Raymond C. Rosen, Ron Hashmonay, Ramagopal Mudumbi, Joel M. Kaufman
Publikováno v:
BJU international. 103(5)
OBJECTIVE To evaluate the overall treatment benefit of dapoxetine for premature ejaculation (PE), with specific emphasis on improvements in personal distress and interpersonal difficulty related to ejaculation. Although these factors are key elements
Autor:
Fisseha Tesfaye, Stephen B. Levine, Ron Hasmonay, Richard Casey, Ramagopal Mudumbi, Raymond C. Rosen
Publikováno v:
Journal of Urology. 177:385-386
Autor:
David L. Rowland, Margaret Rothman, Raymond C. Rosen, Ramagopal Mudumbi, Fisseha Tesfaye, Joel M. Kaufman
Publikováno v:
Journal of Urology. 177:385-385
Publikováno v:
American Journal of Physiology: Heart & Circulatory Physiology; 1988, Vol. 255 Issue 6, pH1492-H1498, 7p
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology; 1990, Vol. 341 Issue 4, p388-390, 3p
Autor:
Ramagopal, Mudumbi V, Mustafa, S Jamal
Publikováno v:
Journal of Pharmacy and Pharmacology; February 1992, Vol. 44 Issue: 2 p133-135, 3p
Publikováno v:
In European Journal of Pharmacology 1989 159(1):33-40
Publikováno v:
In European Journal of Pharmacology 1989 166(2):311-314